{
    "organizations": [],
    "uuid": "a9be04b7dbe3d0e64b27279c9b574a329b7695b6",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-limflow-completes-enrollment-in-us/brief-limflow-completes-enrollment-in-u-s-feasibility-study-and-receives-breakthrough-device-status-from-fda-idUSASM000IMC",
    "ord_in_thread": 0,
    "title": "BRIEF-LimFlow Completes Enrollment In U.S. Feasibility Study And Receives Breakthrough Device Status From FDA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 29 (Reuters) -\n* LIMFLOW COMPLETES ENROLLMENT IN US FEASIBILITY STUDY AND RECEIVES BREAKTHROUGH DEVICE STATUS FROM FDA FOR ITS PERCUTANEOUS DEEP VEIN ARTERIALIZATION (PDVA) SYSTEM Source text for Eikon:\n ",
    "published": "2018-01-29T21:41:00.000+02:00",
    "crawled": "2018-01-30T18:52:47.027+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "limflow",
        "completes",
        "enrollment",
        "u",
        "feasibility",
        "study",
        "receives",
        "breakthrough",
        "device",
        "status",
        "fda",
        "percutaneous",
        "deep",
        "vein",
        "arterialization",
        "pdva",
        "system",
        "source",
        "text",
        "eikon"
    ]
}